Blackrock Neurotech
Founded 2008 · 193 employees on LinkedIn · 4 known investors
Find your way into Blackrock Neurotech
604 people in our graph share verified history with the Blackrock Neurotech team — schools, employers, funds. One of them is your warm intro.
Jan Hammerunlockedknows Marcus Gerhardt · together at University of Oxford (overlapped)
knows the team · via University of Oxford
×4knows the team · via Alliance Manchester Business School
×5knows the team · via University of St Andrews
knows the team · via Technische Universität Berlin
Blackrock Neurotech develops a neurotechnology platform, including brain-computer interface systems, aimed at improving patient lives and treating neurological conditions. It builds implantable neural interface technology for medical and research applications.
Founders & leadership
Blackrock Neurotech was founded in 2008 by Florian Solzbacher and Marcus Gerhardt.
FS
Florian SolzbacherinCo-Founder & CSOFlorian Solzbacher holds a Ph.D. in electrical engineering from Technical University Ilmenau and was previously Chair of the Department of Electrical and Computer Engineering at the University of Utah, where he also directed the Center for Engineering Innovation and held appointments in materials science and biomedical engineering. He co-founded Blackrock Neurotech alongside related ventures in neural interface technology, and has authored over 190 scientific publications and patent applications.
MG
Marcus Gerhardtin𝕏Co-Founder & CEOMarcus Gerhardt holds an MPhil from Oxford University and an MA from St. Andrews. He founded Mondus, an ecommerce platform, in 1999, established BBI to advise technology companies on funding and commercialization, and co-founded a frontier market asset manager in 2003 before becoming CEO of Blackrock Neurotech.
TT
Thomas ThieleinCFOHe has 20+ years of financial and operational experience in manufacturing and technology across the U.S., Europe, and Asia, including SAP and NetSuite implementations, M&A integration, and Big Four audit work, and holds a CPA and PhD in finance.
Board
CA
Christian AngermayerCo-Chairman
TS
Tim SieversCo-Chairman
Investors · 4
Founder mafia
3 people who came through Blackrock Neurotech went on to found or lead other companies.
Non-dilutive funding · 15 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2023 | $1.5M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2023 | $496.4K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2021 | $1.5M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2020 | $1.5M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2020 | $221.2K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2019 | $222.5K |
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2016 | $149.2K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2015 | $709.2K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2014 | $774.5K |
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2014 | $222K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2013 | $700K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2013 | $700K |
| National Science Foundation | Phase ISTTR | 2013 | $224.1K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2011 | $709.8K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2010 | $101.1K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- What does Blackrock Neurotech do?
- Blackrock Neurotech develops a neurotechnology platform, including brain-computer interface systems, aimed at improving patient lives and treating neurological conditions. It builds implantable neural interface technology for medical and research applications.
- Who founded Blackrock Neurotech?
- Blackrock Neurotech was founded by Florian Solzbacher, Marcus Gerhardt in 2008.
- Who are Blackrock Neurotech's investors?
- Blackrock Neurotech's investors include 2050 Capital, Catalio Capital Management, LP, Forepont Capital Partners, Tether.